XDWS:XETRA:XETRA-Xtrackers MSCI World Consumer Staples UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 45.27

Change

-0.63 (-1.36)%

Market Cap

USD 0.73B

Volume

6.23K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.34 (-0.66%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.11 (-0.66%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.24 (-0.88%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.27 (-0.95%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.09 (-0.36%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.08 (-0.76%)

USD 102.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.66 (-1.44%)

USD 101.20B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.33 (-0.65%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.24 (-0.23%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.62 (-0.27%)

USD 80.38B

ETFs Containing XDWS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.18% 60% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.18% 59% D- 61% D-
Trailing 12 Months  
Capital Gain 12.82% 60% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.82% 59% D- 61% D-
Trailing 5 Years  
Capital Gain 31.87% 62% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.87% 58% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.60% 55% F 55% F
Dividend Return 7.60% 54% F 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.15% 70% C- 76% C+
Risk Adjusted Return 93.28% 84% B 86% B+
Market Capitalization 0.73B 72% C 64% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike